Article Menu
Need Help?
No Article Versions Notes Found
Cite
Soriani, S.; Guido, V.; Bertani, G.; Cesana, C.; Motta, V.; De Canal, G.; De Paoli, E.; Veronese, S.; Bonoldi, E.; Romitti, L. BCR/ABL1 Fluorescence In Situ Hybridization Fusion Signals on Both Copies of Chromosome 22 in a Philadelphia-Masked Chronic Myeloid Leukemia Case: Implication for the Therapy. Hematol. Rep. 2021, 13, 8795. https://doi.org/10.4081/hr.2021.8795
Soriani S, Guido V, Bertani G, Cesana C, Motta V, De Canal G, De Paoli E, Veronese S, Bonoldi E, Romitti L. BCR/ABL1 Fluorescence In Situ Hybridization Fusion Signals on Both Copies of Chromosome 22 in a Philadelphia-Masked Chronic Myeloid Leukemia Case: Implication for the Therapy. Hematology Reports. 2021; 13(1):8795. https://doi.org/10.4081/hr.2021.8795
Chicago/Turabian StyleSoriani, Silvia, Valentina Guido, Giambattista Bertani, Clara Cesana, Valentina Motta, Gabriella De Canal, Elena De Paoli, Silvio Veronese, Emanuela Bonoldi, and Lorenza Romitti. 2021. "BCR/ABL1 Fluorescence In Situ Hybridization Fusion Signals on Both Copies of Chromosome 22 in a Philadelphia-Masked Chronic Myeloid Leukemia Case: Implication for the Therapy" Hematology Reports 13, no. 1: 8795. https://doi.org/10.4081/hr.2021.8795
APA StyleSoriani, S., Guido, V., Bertani, G., Cesana, C., Motta, V., De Canal, G., De Paoli, E., Veronese, S., Bonoldi, E., & Romitti, L. (2021). BCR/ABL1 Fluorescence In Situ Hybridization Fusion Signals on Both Copies of Chromosome 22 in a Philadelphia-Masked Chronic Myeloid Leukemia Case: Implication for the Therapy. Hematology Reports, 13(1), 8795. https://doi.org/10.4081/hr.2021.8795
